Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KeraStat Gel with Morphine for Chronic Wound Pain
NCT05217160Phase 4Recruiting
- Sponsor
- Metis Foundation
- Start
- May 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of morphine hydrochloride (2 arms), sponsored by Metis Foundation. Primary endpoints: Visual Analog Scale at 12 weeks and Adverse event assessment at 12 weeks. Started May 2021; status: recruiting.
02
Drugs
morphine hydrochloride
Beyond the preview
Go deeper on NCT05217160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05217160.